BRPI0909769A2 - Composição não-viva contendo carboidrato, e, uso da mesma - Google Patents

Composição não-viva contendo carboidrato, e, uso da mesma

Info

Publication number
BRPI0909769A2
BRPI0909769A2 BRPI0909769-4A BRPI0909769A BRPI0909769A2 BR PI0909769 A2 BRPI0909769 A2 BR PI0909769A2 BR PI0909769 A BRPI0909769 A BR PI0909769A BR PI0909769 A2 BRPI0909769 A2 BR PI0909769A2
Authority
BR
Brazil
Prior art keywords
carbohydrate
containing non
living composition
living
composition
Prior art date
Application number
BRPI0909769-4A
Other languages
English (en)
Inventor
Antonius Arnoldus Christian Jacobs
Paul Vermeij
Ruud Philip Antoon Maria Segers
Carla Christina Schrier
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41212183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0909769(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Priority to BR122019000869-8A priority Critical patent/BR122019000869B1/pt
Publication of BRPI0909769A2 publication Critical patent/BRPI0909769A2/pt
Publication of BRPI0909769B1 publication Critical patent/BRPI0909769B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0909769-4A 2008-04-18 2009-04-16 Uso de uma composição de células integrais inativadas de lawsonia intracellularis contendo carboidrato BRPI0909769B1 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR122019000869-8A BR122019000869B1 (pt) 2008-04-18 2009-04-16 Composição de células integrais inativadas de lawsonia intracellularis contendo carboidrato

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US4616108P 2008-04-18 2008-04-18
EP08154764 2008-04-18
US61/046161 2008-04-18
EP08154764.8 2008-04-18
US11175608P 2008-11-06 2008-11-06
EP08105738.2 2008-11-06
US61/111756 2008-11-06
EP08105738 2008-11-06
PCT/EP2009/054516 WO2009144088A2 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellulars

Publications (2)

Publication Number Publication Date
BRPI0909769A2 true BRPI0909769A2 (pt) 2015-08-11
BRPI0909769B1 BRPI0909769B1 (pt) 2024-07-09

Family

ID=

Also Published As

Publication number Publication date
EP3708186A1 (en) 2020-09-16
CA2717969A1 (en) 2009-12-03
US9198963B2 (en) 2015-12-01
DK2268308T3 (en) 2018-05-22
TW201002342A (en) 2010-01-16
US8597662B2 (en) 2013-12-03
US20130302372A1 (en) 2013-11-14
EP3351267B1 (en) 2020-08-05
HUE038294T2 (hu) 2018-10-29
PL3351267T3 (pl) 2020-11-30
WO2009144088A3 (en) 2010-05-06
EP2268308A2 (en) 2011-01-05
JP2011516600A (ja) 2011-05-26
EP2268308B2 (en) 2026-05-06
US20110033496A1 (en) 2011-02-10
CN102006883A (zh) 2011-04-06
ES2666671T3 (es) 2018-05-07
FR21C1002I1 (fr) 2021-03-05
BR122019000869B1 (pt) 2023-11-07
WO2009144088A2 (en) 2009-12-03
JP6138875B2 (ja) 2017-05-31
TWI551295B (zh) 2016-10-01
HUS2000047I1 (hu) 2020-12-28
JP6026106B2 (ja) 2016-11-16
PL2268308T3 (pl) 2018-07-31
EP2268308B1 (en) 2018-03-14
DK3351267T3 (da) 2020-09-21
CA2717969C (en) 2016-06-07
JP2016026154A (ja) 2016-02-12
US20130045228A1 (en) 2013-02-21
EP3351267A1 (en) 2018-07-25

Similar Documents

Publication Publication Date Title
BRPI0919193A2 (pt) Uso de lipídeo, e, composição nutricional
BRPI0908792A2 (pt) Composição, e, uso de uma combinação
BRPI0914863A2 (pt) formulação tópica estável, e, uso da mesma
BRPI0913447A2 (pt) composição de éster, e, composição para cuidado pessoal.
BRPI0907453A2 (pt) Compostos, uso e preparação dos mesmos
BR112012002349A2 (pt) composto,e, uso do mesmo
BRPI0822121A2 (pt) Composição para cuidado oral, e uso da mesma
BRPI0907365A2 (pt) Composição antimicrobiana e uso
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0821668A2 (pt) Uso
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BRPI0914715A2 (pt) mistura, uso da mistura, e, filme retrátil.
SMT201500218B (it) Composti aril-fenil-solfonammido-cicloalchile e loro uso
NL1036050C (nl) Brandvertragende en brandwerende samenstelling.
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BRPI0915134A2 (pt) composto, e, uso de um composto
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI0919794A2 (pt) dispositivo para uso intracorpóreo, e, composto
BRPI1006996A2 (pt) composição, método e uso
BRPI0818641A2 (pt) Rótulo, e, uso do rótulo
BRPI0907053A2 (pt) Poliisobutenoamina, composição combustível, e, uso de poliisobutenoaminas
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0916943A2 (pt) composição lubrificante, e, uso da mesma

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.